Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.
2.

Predictive value of preoperative magnetic resonance imaging of the pituitary for surgical cure in Cushing's disease.

Witek P, Zielinski G.

Turk Neurosurg. 2012;22(6):747-52. doi: 10.5137/1019-5149.JTN.6199-12.2.

3.

Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.

Prevedello DM, Pouratian N, Sherman J, Jane JA Jr, Vance ML, Lopes MB, Laws ER Jr.

J Neurosurg. 2008 Oct;109(4):751-9. doi: 10.3171/JNS/2008/109/10/0751.

PMID:
18826366
5.

Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas.

Fomekong E, Maiter D, Grandin C, Raftopoulos C.

Clin Neurol Neurosurg. 2009 Jun;111(5):442-9. doi: 10.1016/j.clineuro.2008.12.011. Epub 2009 Feb 5.

PMID:
19200645
6.

Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease.

Rollin G, Ferreira NP, Czepielewski MA.

Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1355-61.

7.

Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre.

Witek P, Zieliński G, Szamotulska K, Maksymowicz M, Kamiński G.

Eur J Endocrinol. 2016 Apr;174(4):539-49. doi: 10.1530/EJE-15-1226. Epub 2016 Jan 25.

8.

Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.

Bakiri F, Tatai S, Aouali R, Semrouni M, Derome P, Chitour F, Benmiloud M.

J Endocrinol Invest. 1996 Oct;19(9):572-80.

PMID:
8957739
9.

Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome?

Burke CW, Adams CB, Esiri MM, Morris C, Bevan JS.

Clin Endocrinol (Oxf). 1990 Oct;33(4):525-37.

PMID:
2171817
10.

Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report.

Andrioli M, Pecori Giraldi F, Losa M, Terreni M, Invitti C, Cavagnini F.

Endocr J. 2010;57(9):833-7. Epub 2010 Jun 26.

11.

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission.

Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF.

Clin Endocrinol (Oxf). 2002 Apr;56(4):541-51.

PMID:
11966748
12.

Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease.

Storr HL, Drake WM, Evanson J, Matson M, Berney DM, Grossman AB, Akker SA, Monson JP, Alusi G, Savage MO, Sabin I.

Clin Endocrinol (Oxf). 2014 Feb;80(2):270-6. doi: 10.1111/cen.12275. Epub 2013 Jul 19.

PMID:
23800132
13.

Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years.

Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müller OA, Fahlbusch R.

J Neurosurg. 2008 Jan;108(1):9-18. doi: 10.3171/JNS/2008/108/01/0009.

PMID:
18173305
14.

Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.

Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB, Savage MO.

Eur J Endocrinol. 2005 Jun;152(6):825-33.

15.

Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.

Wagenmakers MA, Boogaarts HD, Roerink SH, Timmers HJ, Stikkelbroeck NM, Smit JW, van Lindert EJ, Netea-Maier RT, Grotenhuis JA, Hermus AR.

Eur J Endocrinol. 2013 Aug 28;169(3):329-37. doi: 10.1530/EJE-13-0325. Print 2013 Sep.

16.

[Technical aspects and surgical strategy for removal of corticotroph pituitary adenoma].

Perrin G, Stevenaert A, Jouanneau E.

Neurochirurgie. 2002 May;48(2-3 Pt 2):186-214. Review. French.

PMID:
12058125
17.

A corticotroph pituitary adenoma as the initial presentation of familial glucocorticoid deficiency.

Benoit I, Drui D, Chaillous L, Dupas B, Mosnier JF, Charbonnel B, Cariou B.

Eur J Endocrinol. 2009 Jul;161(1):195-9. doi: 10.1530/EJE-09-0100. Epub 2009 May 7.

18.

Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas.

de Bruin C, Pereira AM, Feelders RA, Romijn JA, Roelfsema F, Sprij-Mooij DM, van Aken MO, van der Lelij AJ, de Herder WW, Lamberts SW, Hofland LJ.

J Clin Endocrinol Metab. 2009 Apr;94(4):1118-24. doi: 10.1210/jc.2008-2101. Epub 2009 Jan 13.

PMID:
19141584
19.
20.

A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome.

Arnott RD, Pestell RG, McKelvie PA, Henderson JK, McNeill PM, Alford FP.

Acta Endocrinol (Copenh). 1990 Oct;123(4):423-30.

PMID:
2173325
Items per page

Supplemental Content

Write to the Help Desk